gilbert semaglutide & tirzepatide are transforming diabetes & obesity management. These GLP-1 receptor agonists offer benefits from glycemic control to weight loss and cardiovascular risk reduction, emphasizing their broad impact. Read more from Semaglutide & Tirzepatide Weight Loss

Each treatment page includes mechanism descriptions, dosing information, and eligibility criteria

To view or add a comment, sign in Exciting to see an insightful new Lilly study using Truveta Data, where they greater weight loss with tirzepatide compared to semaglutide among adults with obesity in routine clinical care

Watch For Thirst Red Flags: How To Spot Dehydration Early Headache Fatigue Lightheadedness Dry mouth Low urine output Urine that is dark yellow or amber If you have vomiting or diarrhea while on a weight loss drug, you face a higher risk of dehydration and should boost fluids and electrolytes

It mimics the bodys own GLP-1 hormone, which plays a key role in insulin secretion and appetite regulation